In an in vitro assay, WT1 CAR-T cells identified and lyzed WT1+/HLA-A*02:01+ tumor cell lines (AML, AML-14; CML, BV173; ovarian cancer, OVCAR3) [124] (Fig. 2). Here, WT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.